Cover Image
市場調查報告書

美國的癌症治療用介入設備市場概要 2016年

US Market Overview for Interventional Oncology Devices 2016 - MedView

出版商 iData Research Inc. 商品編碼 360571
出版日期 內容資訊 英文 92 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的癌症治療用介入設備市場概要 2016年 US Market Overview for Interventional Oncology Devices 2016 - MedView
出版日期: 2016年01月02日 內容資訊: 英文 92 Pages
簡介

本報告提供美國的癌症治療用介入設備市場調查分析,市場概要,市場分析與預測,推動因素、阻礙因素,競爭分析,產品概要,及各癌症類型的發病率等系統性資訊。

摘要整理

分析方法

  • 分析範圍
  • IDATA的9階段的分析方法

美國的癌症治療用介入設備市場概要

  • 簡介
    • 產品
      • 放射治療
      • 切除治療
      • 粒子狀栓塞
  • 市場概要
  • 趨勢分析
  • 促進要素、抑制因素
  • 競爭分析
  • M&A

癌症的發病率

  • 簡介
  • 癌症:各類型
    • 性器官癌症
    • 消化器官系統的癌症
    • 呼吸系統的癌症
    • 乳癌
    • 膀胱癌
    • 皮膚癌
    • 淋巴瘤
    • 內分泌系的癌症
    • 白血病
    • 口腔癌/喉癌
    • 骨髓瘤
    • 腦/其他神經系統的癌症
    • 軟組織的癌症 (心臟之外)
    • 骨、關節的癌症
    • 眼、眼窩的癌症

簡稱一覽

圖表一覽

目錄
Product Code: iDATA_USONCMO16_RPT

The U.S. market for IO devices is broken up into radiation therapy (RT), which includes internal (RTi) and external (RTx) radiation therapy; ablation, which includes cryoablation therapy, microwave ablation therapy (MAT) and radiofrequency ablation (RFA); and particle embolization, which includes drug-eluting beads, radioembolization, microspheres and polyvinyl alcohol (PVA) particles.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY FOR COMPLETE REPORT SUITE

  • 1.1. MARKET OVERVIEW
  • 1.2. COMPETITIVE LANDSCAPE
  • 1.3. MARKET TRENDS
  • 1.4. KEY MARKET DEVELOPMENTS
  • 1.5. INCIDENCE RATES INCLUDED
  • 1.6. PROCEDURE NUMBERS
  • 1.7. MARKETS INCLUDED
  • 1.8. KEY REPORT UPDATES
  • 1.9. VERSION HISTORY

RESEARCH METHODOLOGY

  • 2.1. RESEARCH SCOPE
  • 2.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

U.S. INTERVENTIONAL ONCOLOGY DEVICE MARKET OVERVIEW

  • 3.1. INTRODUCTION
    • 3.1.1. Products
      • 3.1.1.1. Radiation Therapy
      • 3.1.1.2. Ablation Therapy
      • 3.1.1.3. Particle Embolization
  • 3.2. MARKET OVERVIEW
  • 3.3. TREND ANALYSIS
  • 3.4. DRIVERS AND LIMITERS
    • 3.4.1. Market Drivers
    • 3.4.2. Market Limiters
  • 3.5. COMPETITIVE ANALYSIS
  • 3.6. MERGERS AND ACQUISITIONS

CANCER INCIDENCE RATES

  • 4.1. INTRODUCTION
  • 4.2. CANCER BY TYPE
    • 4.2.1. Genital Cancer
    • 4.2.2. Digestive Cancer
    • 4.2.3. Respiratory Cancer
    • 4.2.4. Breast Cancer
    • 4.2.5. Urinary Cancer
    • 4.2.6. Skin Cancer
    • 4.2.7. Lymphoma
    • 4.2.8. Endocrine System Cancer
    • 4.2.9. Leukemia
    • 4.2.10. Oral Cavity/Larynx
    • 4.2.11. Myeloma
    • 4.2.12. Brain/Other Nervous System
    • 4.2.13. Soft Tissue (Non-Heart)
    • 4.2.14. Bones and Joints
    • 4.2.15. Eye and Orbit

ABBREVIATIONS

LIST OF CHARTS

  • Chart 1-1: Interventional Oncology Device Market by Segment, U.S., 2012-2022 (US$M)
  • Chart 1-2: Interventional Oncology Device Market Overview, U.S., 2015 & 2022
  • Chart 3-1: Interventional Oncology Device Market by Segment, U.S., 2012-2022
  • Chart 3-2: Interventional Oncology Device Market Breakdown, U.S., 2015
  • Chart 3-3: Interventional Oncology Device Market Breakdown, U.S., 2022
  • Chart 3-4: Growth by Segment, Interventional Oncology Device Market, U.S., 2012-2022
  • Chart 3-5: Leading Competitors, Interventional Oncology Device Market, U.S., 2015
  • Chart 4-1: Male Incidence, Genital Cancer, U.S., 2014
  • Chart 4-2: Male Deaths, Genital Cancer, U.S., 2014
  • Chart 4-3: Female Incidence, Genital Cancer, U.S., 2014
  • Chart 4-4: Female Deaths, Genital Cancer, U.S., 2014
  • Chart 4-5: Male Incidence, Digestive Cancer, U.S., 2014
  • Chart 4-6: Male Deaths, Digestive Cancer, U.S., 2014
  • Chart 4-7: Female Incidence, Digestive Cancer, U.S., 2014
  • Chart 4-8: Female Deaths, Digestive Cancer, U.S., 2014
  • Chart 4-9: Male Incidence, Respiratory Cancer, U.S., 2014
  • Chart 4-10: Male Deaths, Respiratory Cancer, U.S., 2014
  • Chart 4-11: Female Incidence, Respiratory Cancer, U.S., 2014
  • Chart 4-12: Female Deaths, Respiratory Cancer, U.S., 2014
  • Chart 4-13: Incidence by Gender, Breast Cancer, U.S., 2014
  • Chart 4-14: Deaths by Gender, Breast Cancer, U.S., 2014
  • Chart 4-15: Male Incidence, Urinary Cancer, U.S., 2014
  • Chart 4-16: Male Deaths, Urinary Cancer, U.S., 2014
  • Chart 4-17: Female Incidence, Urinary Cancer, U.S., 2014
  • Chart 4-18: Female Deaths, Urinary Cancer, U.S., 2014
  • Chart 4-19: Male Incidence, Skin Cancer, U.S., 2014
  • Chart 4-20: Male Deaths, Skin Cancer, U.S., 2014
  • Chart 4-21: Female Incidence, Skin Cancer, U.S., 2014
  • Chart 4-22: Female Deaths, Skin Cancer, U.S., 2014
  • Chart 4-23: Male Incidence, Lymphoma Cancer, U.S., 2014
  • Chart 4-24: Male Deaths, Lymphoma Cancer, U.S., 2014
  • Chart 4-25: Female Incidence, Lymphoma Cancer, U.S., 2014
  • Chart 4-26: Female Deaths, Lymphoma Cancer, U.S., 2014
  • Chart 4-27: Male Incidence, Endocrine Cancer, U.S., 2014
  • Chart 4-28: Male Deaths, Endocrine Cancer, U.S., 2014
  • Chart 4-29: Female Incidence, Endocrine Cancer, U.S., 2014
  • Chart 4-30: Female Deaths, Endocrine Cancer, U.S., 2014
  • Chart 4-31: Male Incidence, Leukemia Cancer, U.S., 2014
  • Chart 4-32: Male Deaths, Leukemia Cancer, U.S., 2014
  • Chart 4-33: Female Incidence, Leukemia Cancer, U.S., 2014
  • Chart 4-34: Female Deaths, Leukemia Cancer, U.S., 2014
  • Chart 4-35: Male Incidence, Oral Cavity/Larynx Cancer, U.S., 2014
  • Chart 4-36: Male Deaths, Oral Cavity/Larynx Cancer, U.S., 2014
  • Chart 4-37: Female Incidence, Oral Cavity/Larynx Cancer, U.S., 2014
  • Chart 4-38: Female Deaths, Oral Cavity/Larynx Cancer, U.S., 2014
  • Chart 4-39: Incidence by Gender, Myeloma Cancer, U.S., 2014
  • Chart 4-40: Deaths by Gender, Myeloma Cancer, U.S., 2014
  • Chart 4-41: Incidence by Gender, Brain/Other Nervous System Cancer, U.S., 2014
  • Chart 4-42: Deaths by Gender, Brain/Other Nervous System Cancer, U.S., 2014
  • Chart 4-43: Incidence by Gender, Soft Tissue Cancer, U.S., 2014
  • Chart 4-44: Deaths by Gender, Soft Tissue Cancer, U.S., 2014
  • Chart 4-45: Incidence by Gender, Bone and Joint Cancers, U.S., 2014
  • Chart 4-46: Deaths by Gender, Bone and Joint Cancers, U.S., 2014
  • Chart 4-47: Incidence by Gender, Eye and Orbit Cancers, U.S., 2014
  • Chart 4-48: Deaths by Gender, Eye and Orbit Cancers, U.S., 2014

LIST OF FIGURES

  • Figure 1-1: Interventional Oncology Device Market Share Ranking by Segment, U.S., 2015
  • Figure 1-2: Companies Research in this Report Suite, U.S., 2015
  • Figure 1-3: Factors Impacting the Interventional Oncology Device Market by Segment, U.S.
  • Figure 1-4: Recent Events in the Interventional Oncology Device Market, U.S., 2012-2015 (1 of 3)
  • Figure 1-5: Recent Events in the Interventional Oncology Device Market, U.S., 2012-2015 (2 of 3)
  • Figure 1-6: Recent Events in the Interventional Oncology Device Market, U.S., 2012-2015 (3 of 3)
  • Figure 1-7: Cancer Incidence Rates Covered, U.S., 2015 (1 of 2)
  • Figure 1-8: Cancer Incidence Rates Covered, U.S., 2015 (2 of 2)
  • Figure 1-9: Interventional Oncology Procedures Covered, U.S., 2015
  • Figure 1-10: Procedural Codes, U.S., 2015
  • Figure 1-11: Interventional Oncology Device Markets Covered, U.S., 2012-2022 (1 of 2)
  • Figure 1-12: Interventional Oncology Device Markets Covered, U.S., 2012-2022 (2 of 2)
  • Figure 1-13: Key Report Updates, U.S., 2016
  • Figure 1-14: Version History
  • Figure 3-1: Interventional Oncology Device Market by Segment, U.S., 2012-2022 (US$M)
  • Figure 3-2: Growth by Segment, Interventional Oncology Device Market, U.S., 2012-2022
  • Figure 3-3: Drivers and Limiters, Interventional Oncology Device Market, U.S., 2015
  • Figure 3-4: Leading Competitors, Interventional Oncology Device Market, U.S., 2015
  • Figure 4-1: Genital Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 4-2: Digestive Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 4-3: Respiratory Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 4-4: Breast Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 4-5: Urinary Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 4-6: Skin Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 4-7: Lymphoma Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 4-8: Endocrine Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 4-9: Leukemia Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 4-10: Oral Cavity/Larynx Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 4-11: Myeloma Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 4-12: Brain/Other Nervous System Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 4-13: Soft Tissue (Non-Heart) Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 4-14: Bone and Joint Cancer Statistics by Type and Gender, U.S., 2014
  • Figure 4-15: Bone and Joint Cancer Statistics by Type and Gender, U.S., 2014
Back to Top